MD Healthcare, Inc. is engaged in developing innovative precision medical solutions based on micro biome data. The company was founded in January, 2014 and is headquartered in Seoul, South Korea.

Manufactures vaccines for diseases like hepatitis, influenza, rubella and typhoid fever

BLIS Technologies Ltd. engages in the development of healthcare products based on strains of bacteria that produce bacteriocin activity. It operates in the following geographical areas: Asia Pacific, Europe Middle East and Africa (EMEA), and North America. The company was founded by John R. Tagg in 2000 and is headquartered in Dunedin, New Zealand.

Novartis AG is a holding company, which engages in the development, manufacture, and marketing of healthcare products. It operates through the following segments: Innovative Medicines, Sandoz, and Corporate. The Innovative Medicines segment researches, develops, manufactures, distributes and sells patented pharmaceuticals, and is composed of two business units: Novartis Oncology and Novartis Pharmaceuticals. The Sandoz segment develops, manufactures and markets finished dosage form medicines as well as intermediary products, including active pharmaceutical ingredients. The Corporate segment refers to group management and central services. The company was founded on February 29, 1996 and is headquartered in Basel, Switzerland.

Genovis AB engages in the research and development of enzyme products. Its product portfolio includes SmartEnzymes, which offers to pharmaceutical and medical device industries tools that facilitate the development of new treatment methods and diagnostics. The company was founded by Inga Sarah Maria Fredriksson in 1999 and is headquartered in Lund, Sweden.

AntibioTx ApS is a private company headquartered in Kongens Lyngby, Denmark, that develops and manufactures pharmaceutical products.

Massachusetts General Hospital was established to provide care to Boston's sick, regardless of socioeconomic status—an innovative idea in 1811. In the words of their founder, John Warren, MD, “When in distress, every man becomes their neighbor.” They subsequently became the first teaching hospital for Harvard University’s new medical school and have been redefining excellence in healthcare ever since. They have remained at the forefront of medicine by fostering a culture of collaboration, pushing the boundaries of medical research, educating the brightest medical minds and maintaining an unwavering commitment to the diverse community they were created to serve. They believe that because of diversity they excel, through inclusion they respect their community, and with a keen focus on equity they serve, heal, educate and innovate at the highest levels. Their first priority is the well-being of their patients—near and far. As a team they are able to maintain a singular focus on providing the highest quality, most compassionate care to each and every patient.

F. Hoffmann-La Roche Ltd. manufactures pharmaceutical products. It offers pharmaceutical drugs, pharmaceutical instruments, and diagnostics solutions. The company was founded by Fritz Hoffmann-La Roche on October 1, 1896 and is headquartered in Basel, Switzerland.

Shire BioChem, Inc. provides pharmaceutical sales and marketing services in Canada. The company is headquartered in Laval, Canada.

UNION therapeutics A/S is a privately held, clinical stage, pharmaceutical company dedicated to the development of molecules exhibiting both immunomodulatory and microbiological effects. UNION is focused on the treatment of inflammatory skin disease and COVID-19, but the chemistry platform is applicable across a wide range of diseases.

ToolGen, a biotechnology company, focuses on the development of genome editing technology. Its products include gRNA/Cas9 purified that provides ready-to-use reagents for genome engineering experiments; gRNA/Cas9 plasmid that offers tools for genome editing experiment; and recombinant Cas9 protein that offers ready-to-use reagents for genome engineering experiments. ToolGen also offers genome-edited cell line; genome-edited mouse/rat; and genome-edited plant services, as well as surrogate reporter synthesis and in-del analysis services. Its products are used in research applications. ToolGen began operation in 1999, with its headquarters in Seoul in South Korea. ToolGen is a subsidiary of NSN.

Fixed Phage was founded with the aim of developing new products for various industries from our platform technology. Each of our core technologies is comprehensively described and protected by our IP portfolio. We work at our custom designed laboratory and support infrastructure facilities located at the prestigious West of Scotland Science Park. Our in-house abilities include all work required to identify, manufacture and work with bacteriophage. Fixed Phage continually invests in innovation and our team presents at conferences and exhibitions around the world. To learn about whether we will be presenting near you, please follow us on social media.

Qingdao Vland Biotech Co., Ltd. engages in R&D, production and sales of enzyme preparations, probiotics and animal health products. It mainly specializes in the research and development of four main product categories which are enzymes, probiotics, vaccines and animal health products. It provides solutions to an industries including agriculture, animal husbandry, textile, paper making, household cleaning and detergents, food, biofuel and environmental protection. The company was founded on February 23, 2005 and is headquartered in Qingdao, China.

Jiangsu Kerong Biopharmaceutical Co., Ltd., established on 2022-05-18, Business scope includes licensed projects:Disinfectant production(Free of Hazardous Chemicals);Production of sterile equipment;Production of hygiene products and single-use medical products;food production;Production of food detergents;Cosmetic production(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,Specific business projects are subject to approval results) General project:Technical Services,technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion;food sales(Only sell prepackaged food);Sales of hygiene products and single-use medical products;Personal Hygiene Sales;Sales of Class I Medical Devices;Sales of Class II Medical Devices;Production of Class I Medical Devices;Disinfectant sales(Free of Hazardous Chemicals);Pet Food and Supplies Wholesale;Pet food and supplies retail;Manufacturing of daily chemical products;Sales of daily chemical products;Maternal and baby products sales;internet sales(Except for products that require a license for sale)(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license)

Pharmacos Exakta SA de CV (doing business as Exakta-OPKO), part of OPKO Health, Inc., is a Mexican company located in Guadalajara. The firm develops, manufactures and supplies pharmaceutical products. On February 18, 2010 OPKO Health, Inc. acquired Pharmacos Exakta SA de CV for $4.39 million.

Beijing Bai'ao Yikang Pharmaceutical Technology Co., Ltd., established on 2021-12-24, Business scope includes technology development,Technical Services,technical consulting,Technology Exchange,technology transfer,Technology Promotion,Technical testing;Medical Research and Experimental Development;Information Consulting Service(Not including licensing information consulting services);Conference Services;Undertake exhibition and display activities;Sales of medical devices Class I,Class II;Production of medical devices Class I,General instrumentation;selling computers,Software, hardware and auxiliary equipment;Natural science research and experimental development;Class III medical device business;Production of Class II Medical Devices;Production of Class III Medical Devices.(Market entities independently choose business projects in accordance with the law,Carry out business activities;Class III medical device business,Production of Class II Medical Devices,Production of Class III medical devices and items subject to approval according to law,Carry out business activities in accordance with the approved content after approval by relevant departments;Do not engage in the business activities of projects prohibited and restricted by the industrial policies of the state and this city.)

Qingdao Weilan Biological Group Co., Ltd., established on 2007-08-22, Business scope includes licensed projects:Import and export;Technology Import and Export;food business(Selling prepackaged food);Catering Services;Food Internet Sales;Food Internet Sales(Selling prepackaged food);food business;Health food sales;Sales of formula food for special medical purposes;Veterinary drug business.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,The specific business items are subject to the approval documents or licenses of relevant departments)General project:Research and development of bio-based materials technology;R&D of industrial enzyme preparations;Biomass liquid fuel production process research and development;Bio-feed R&D;Bio-organic fertilizer research and development;Fermentation process optimization technology research and development;Biochemical product technology research and development;Extraction of marine bioactive substances,purification,Synthesis technology research and development;R&D and application of cell technology;Technical Services,technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion;Food Additive Sales;Engage in investment activities with own funds;Animal Husbandry and Fishery Feed Sales;Feed Raw Material Sales;Feed Additive Sales;business management;property management;Conference and Exhibition Services;internet sales(Except for products that require a license for sale);Cosmetics Wholesale;Cosmetics Retail;Sales of hygiene products and single-use medical products;Personal Hygiene Sales;Daily necessities sales;Daily necessities wholesale;Daily miscellaneous goods sales;Pet Food and Supplies Wholesale;Pet food and supplies retail;Information Consulting Service(Not including licensing information consulting services);Information Technology Consulting Services;Health Consulting Services(Does not include medical services);Development of Human Gene Diagnosis and Therapy Technology;Chemical product sales(No licensed chemical products);Sales of Class I Medical Devices;Disinfectant sales(Free of Hazardous Chemicals);Business Management Consulting;Educational Consulting Services(Education and training activities that do not include licensing approval).(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license)

Novartis Vaccines & Diagnostics, Inc. manufactures and markets health care and nutritional products. The company was founded in 1986 and is headquartered in East Hanover, NJ.